Diabetes outcomes before and during telehealth advancements surrounding COVID-19

BACKGROUND: Pharmacists can optimize outcomes related to type-2 diabetes (T2D) by taking advantage of telehealth opportunities despite the coronavirus 2019 (COVID-19) Public Health Emergency (PHE). OBJECTIVE: Identify and compare changes in T2D outcomes before (August 2019 through February 2020) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Woodhouse, Ashley G., Orvin, Chelsea, Rich, Caleb, Crosby, Joseph, Keedy, Chelsea A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Pharmacists Association®. Published by Elsevier Inc. 2022
Materias:
Science and Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479448/
https://www.ncbi.nlm.nih.gov/pubmed/34635442
http://dx.doi.org/10.1016/j.japh.2021.09.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479448/
https://www.ncbi.nlm.nih.gov/pubmed/34635442
http://dx.doi.org/10.1016/j.japh.2021.09.011

Ejemplares similares